Outcome of therapies for membranous glomerulonephritis during three waves of COVID pandemic
There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COV...
Gespeichert in:
| Veröffentlicht in: | Indian journal of nephrology 2023-07, Vol.33 (4), p.289-291 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 291 |
|---|---|
| container_issue | 4 |
| container_start_page | 289 |
| container_title | Indian journal of nephrology |
| container_volume | 33 |
| creator | Kumar, Asheesh Singh, Ram Chauhan, Ashish Sharma, Dheeraj Sandal, Rajeev Chauhan, Naresh Gupta, Samriti Verma, Balbir |
| description | There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection. |
| doi_str_mv | 10.4103/ijn.ijn_162_22 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2871657000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A764620994</galeid><sourcerecordid>A764620994</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489e-8e9f7fbf95891f551622532da2abe3c326a010acb46f58da9e8de059319e0e883</originalsourceid><addsrcrecordid>eNp9ks9rFDEUx4NYcG29eh4QxMus-THJJMeyVi0W9qJePITszMtutplkTGZc_O_N2kptqRJCIHw-772EL0IvCV42BLO3bh-WZWsiqKb0CVoQpWTNhKBP0QKrltQNFvwZep7zHmPKG8UX6Nt6nro4QBVtNe0gmdFBrmxM1QDDJpkQ51xtfSHS7GOAcZfc5HLVz8mFbVESQHUwP4pUKqzWXy_fVaMJPQyuO0Mn1vgML27PU_Tl_cXn1cf6av3hcnV-VXeNVFBLULa1G6u4VMRyXuannNHeULMB1jEqDCbYdJtGWC57o0D2gLliRAEGKdkpenNTd0zx-wx50oPLHXhvApTxNZUtEbzFGBf01QN0H-cUynSaEUIa1tL_U1SK0rfFtL2jtsaDdsHGKZnu2Fqft6IRFCvVFGr5CFXW7y8qP2pdub8nvP5L2IHx0y5HP08uhvxo5S7FnBNYPSY3mPRTE6yPidDHNNwlogifboRD9BOkfO3nAyQ9QH8d4uEfVnmx0rch0dHqPyFhvwACfcL8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2863197027</pqid></control><display><type>article</type><title>Outcome of therapies for membranous glomerulonephritis during three waves of COVID pandemic</title><source>Medknow Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kumar, Asheesh ; Singh, Ram ; Chauhan, Ashish ; Sharma, Dheeraj ; Sandal, Rajeev ; Chauhan, Naresh ; Gupta, Samriti ; Verma, Balbir</creator><creatorcontrib>Kumar, Asheesh ; Singh, Ram ; Chauhan, Ashish ; Sharma, Dheeraj ; Sandal, Rajeev ; Chauhan, Naresh ; Gupta, Samriti ; Verma, Balbir</creatorcontrib><description>There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection.</description><identifier>ISSN: 0971-4065</identifier><identifier>EISSN: 1998-3662</identifier><identifier>DOI: 10.4103/ijn.ijn_162_22</identifier><language>eng</language><publisher>Mumbai: Wolters Kluwer India Pvt. Ltd</publisher><subject>Care and treatment ; COVID-19 ; Health aspects ; Immunotherapy ; Infection ; Kidney diseases ; Nephrology ; Virus diseases</subject><ispartof>Indian journal of nephrology, 2023-07, Vol.33 (4), p.289-291</ispartof><rights>COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.</rights><rights>2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c489e-8e9f7fbf95891f551622532da2abe3c326a010acb46f58da9e8de059319e0e883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27458,27924,27925</link.rule.ids></links><search><creatorcontrib>Kumar, Asheesh</creatorcontrib><creatorcontrib>Singh, Ram</creatorcontrib><creatorcontrib>Chauhan, Ashish</creatorcontrib><creatorcontrib>Sharma, Dheeraj</creatorcontrib><creatorcontrib>Sandal, Rajeev</creatorcontrib><creatorcontrib>Chauhan, Naresh</creatorcontrib><creatorcontrib>Gupta, Samriti</creatorcontrib><creatorcontrib>Verma, Balbir</creatorcontrib><title>Outcome of therapies for membranous glomerulonephritis during three waves of COVID pandemic</title><title>Indian journal of nephrology</title><description>There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection.</description><subject>Care and treatment</subject><subject>COVID-19</subject><subject>Health aspects</subject><subject>Immunotherapy</subject><subject>Infection</subject><subject>Kidney diseases</subject><subject>Nephrology</subject><subject>Virus diseases</subject><issn>0971-4065</issn><issn>1998-3662</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9ks9rFDEUx4NYcG29eh4QxMus-THJJMeyVi0W9qJePITszMtutplkTGZc_O_N2kptqRJCIHw-772EL0IvCV42BLO3bh-WZWsiqKb0CVoQpWTNhKBP0QKrltQNFvwZep7zHmPKG8UX6Nt6nro4QBVtNe0gmdFBrmxM1QDDJpkQ51xtfSHS7GOAcZfc5HLVz8mFbVESQHUwP4pUKqzWXy_fVaMJPQyuO0Mn1vgML27PU_Tl_cXn1cf6av3hcnV-VXeNVFBLULa1G6u4VMRyXuannNHeULMB1jEqDCbYdJtGWC57o0D2gLliRAEGKdkpenNTd0zx-wx50oPLHXhvApTxNZUtEbzFGBf01QN0H-cUynSaEUIa1tL_U1SK0rfFtL2jtsaDdsHGKZnu2Fqft6IRFCvVFGr5CFXW7y8qP2pdub8nvP5L2IHx0y5HP08uhvxo5S7FnBNYPSY3mPRTE6yPidDHNNwlogifboRD9BOkfO3nAyQ9QH8d4uEfVnmx0rch0dHqPyFhvwACfcL8</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Kumar, Asheesh</creator><creator>Singh, Ram</creator><creator>Chauhan, Ashish</creator><creator>Sharma, Dheeraj</creator><creator>Sandal, Rajeev</creator><creator>Chauhan, Naresh</creator><creator>Gupta, Samriti</creator><creator>Verma, Balbir</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Scientific Scholar</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20230701</creationdate><title>Outcome of therapies for membranous glomerulonephritis during three waves of COVID pandemic</title><author>Kumar, Asheesh ; Singh, Ram ; Chauhan, Ashish ; Sharma, Dheeraj ; Sandal, Rajeev ; Chauhan, Naresh ; Gupta, Samriti ; Verma, Balbir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489e-8e9f7fbf95891f551622532da2abe3c326a010acb46f58da9e8de059319e0e883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Care and treatment</topic><topic>COVID-19</topic><topic>Health aspects</topic><topic>Immunotherapy</topic><topic>Infection</topic><topic>Kidney diseases</topic><topic>Nephrology</topic><topic>Virus diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Asheesh</creatorcontrib><creatorcontrib>Singh, Ram</creatorcontrib><creatorcontrib>Chauhan, Ashish</creatorcontrib><creatorcontrib>Sharma, Dheeraj</creatorcontrib><creatorcontrib>Sandal, Rajeev</creatorcontrib><creatorcontrib>Chauhan, Naresh</creatorcontrib><creatorcontrib>Gupta, Samriti</creatorcontrib><creatorcontrib>Verma, Balbir</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Indian journal of nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Asheesh</au><au>Singh, Ram</au><au>Chauhan, Ashish</au><au>Sharma, Dheeraj</au><au>Sandal, Rajeev</au><au>Chauhan, Naresh</au><au>Gupta, Samriti</au><au>Verma, Balbir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcome of therapies for membranous glomerulonephritis during three waves of COVID pandemic</atitle><jtitle>Indian journal of nephrology</jtitle><date>2023-07-01</date><risdate>2023</risdate><volume>33</volume><issue>4</issue><spage>289</spage><epage>291</epage><pages>289-291</pages><issn>0971-4065</issn><eissn>1998-3662</eissn><abstract>There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection.</abstract><cop>Mumbai</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><doi>10.4103/ijn.ijn_162_22</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0971-4065 |
| ispartof | Indian journal of nephrology, 2023-07, Vol.33 (4), p.289-291 |
| issn | 0971-4065 1998-3662 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2871657000 |
| source | Medknow Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Care and treatment COVID-19 Health aspects Immunotherapy Infection Kidney diseases Nephrology Virus diseases |
| title | Outcome of therapies for membranous glomerulonephritis during three waves of COVID pandemic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T17%3A09%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcome%20of%20therapies%20for%20membranous%20glomerulonephritis%20during%20three%20waves%20of%20COVID%20pandemic&rft.jtitle=Indian%20journal%20of%20nephrology&rft.au=Kumar,%20Asheesh&rft.date=2023-07-01&rft.volume=33&rft.issue=4&rft.spage=289&rft.epage=291&rft.pages=289-291&rft.issn=0971-4065&rft.eissn=1998-3662&rft_id=info:doi/10.4103/ijn.ijn_162_22&rft_dat=%3Cgale_proqu%3EA764620994%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2863197027&rft_id=info:pmid/&rft_galeid=A764620994&rfr_iscdi=true |